Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT02129205
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of advanced/metastatic solid tumor that is resistant to standard therapy or for which no standard therapy is available
* Previously treated metastatic triple negative breast cancer that expresses Notch3 with at least one measurable lesion
* Adequate bone marrow, renal and liver function
Exclusion Criteria:
* Major surgery, radiation therapy or systemic anti-cancer therapy within 4 weeks of starting study treatment
* Patients with known symptomatic brain metastases requiring steroids
* Prior treatment with a compound of the same mechanism
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02129205
Study Brief:
Protocol Section:
NCT02129205